Literature DB >> 3760958

Hypothalamic dysfunction following whole-brain irradiation.

J I Mechanick, F H Hochberg, A LaRocque.   

Abstract

The authors describe 15 cases with evidence of hypothalamic dysfunction 2 to 9 years following megavoltage whole-brain x-irradiation for primary glial neoplasm. The patients received 4000 to 5000 rads in 180- to 200-rad fractions. Dysfunction occurred in the absence of computerized tomography-delineated radiation necrosis or hypothalamic invasion by tumor, and antedated the onset of dementia. Fourteen patients displayed symptoms reflecting disturbances of personality, libido, thirst, appetite, or sleep. Hyperprolactinemia (with prolactin levels up to 70 ng/ml) was present in all of the nine patients so tested. Of seven patients tested with thyrotropin-releasing hormone, one demonstrated an abnormal pituitary gland response consistent with a hypothalamic disorder. Seven patients developed cognitive abnormalities. Computerized tomography scans performed a median of 4 years after tumor diagnosis revealed no hypothalamic tumor or diminished density of the hypothalamus. Cortical atrophy was present in 50% of cases and third ventricular dilatation in 58%. Hypothalamic dysfunction, heralded by endocrine, behavioral, and cognitive impairment, represents a common, subtle form of radiation damage.

Entities:  

Mesh:

Year:  1986        PMID: 3760958     DOI: 10.3171/jns.1986.65.4.0490

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

Review 1.  Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis.

Authors:  Natasha M Appelman-Dijkstra; Nieke E Kokshoorn; Olaf M Dekkers; Karen J Neelis; Nienke R Biermasz; Johannes A Romijn; Johannes W A Smit; Alberto M Pereira
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

2.  Prognosis of intracranial germ cell tumours: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16).

Authors:  J Yoshida; K Sugita; T Kobayashi; K Takakura; N Shitara; M Matsutani; R Tanaka; H Nagai; H Yamada; J Yamashita
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

3.  SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease.

Authors:  Gabriele Calaminus; Rolf Kortmann; Jennifer Worch; James C Nicholson; Claire Alapetite; Maria Luisa Garrè; Catherine Patte; Umberto Ricardi; Frank Saran; Didier Frappaz
Journal:  Neuro Oncol       Date:  2013-03-03       Impact factor: 12.300

4.  Carboplatin-based regimen in pediatric intracranial germ-cell tumors (IC-GCTs): effectiveness and ototoxicity.

Authors:  Rasin Worawongsakul; Nongnuch Sirachainan; Apimid Rojanawatsirivej; Atthaporn Boongird; Arunee Singhsnaeh; Thiti Swangsilpa; Mantana Dhanachai; Putipun Puataweepong; Rawee Ruangkanchanasetr; Samart Pakakasama; Usanarat Anurathapan; Duantida Songdej; Pongpak Pongphitcha; Chaiyos Khongkhatithum; Ake Hansasuta; Nintita Sripaiboonkij Thokanit; Apasri Lusawat; Sarunya Yuthagovit; Samasuk Thammachantha; Danupon Muangruk; Suradej Hongeng
Journal:  Neurooncol Pract       Date:  2019-09-30

Review 5.  A case report of Wyburn-Mason syndrome and review of the literature.

Authors:  P N Dayani; A A Sadun
Journal:  Neuroradiology       Date:  2007-01-18       Impact factor: 2.995

6.  Are hypothalamic- pituitary (HP) axis deficiencies after whole brain radiotherapy (WBRT) of relevance for adult cancer patients? - a systematic review of the literature.

Authors:  P Mehta; F B Fahlbusch; D Rades; S M Schmid; J Gebauer; S Janssen
Journal:  BMC Cancer       Date:  2019-12-12       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.